Compounds > gemcitabine
Page last updated: 2024-08-24

gemcitabine and Leukemia L 1210

gemcitabine has been researched along with Leukemia L 1210 in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's5 (55.56)18.2507
2000's3 (33.33)29.6817
2010's1 (11.11)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baze, WB; Cui, Z; Finch, RA; Jolly, CA; Naguib, YW; Valdes, S1
Arias, JL; Couvreur, P; Reddy, LH1
Cros, E; Dumontet, C; Galmarini, CM; Gouy, MH; Jordheim, LP; Mackey, J; Perigaud, C; Peyrottes, S1
Cory, AH; Cory, JG1
Cory, AH; Cory, JG; Hertel, LW; Kroin, JS1
Marańda, E; Robak, T1
Bergman, AM; Brouwer, M; Eriksson, S; Jongsma, AP; Leyva, A; Peters, GJ; Pinedo, HM; Ruiz van Haperen, VW; Veerman, G1
Marañda, E; Robak, T; Szmigielska, A1
Boder, GB; Grindey, GB; Hertel, LW; Kroin, JS; Poore, GA; Rinzel, SM; Todd, GC1

Other Studies

9 other study(ies) available for gemcitabine and Leukemia L 1210

ArticleYear
Preclinical Evaluation of the Short-Term Toxicity of 4-(N)-Docosahexaenoyl 2´, 2´- Difluorodeoxycytidine (DHA-dFdC).
    Pharmaceutical research, 2017, Volume: 34, Issue:6

    Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Deoxycytidine; Drug Compounding; Female; Gemcitabine; Humans; Leukemia L1210; Maximum Tolerated Dose; Mice, Inbred DBA

2017
Polymeric nanoparticulate system augmented the anticancer therapeutic efficacy of gemcitabine.
    Journal of drug targeting, 2009, Volume: 17, Issue:8

    Topics: Animals; Antimetabolites, Antineoplastic; Cyanoacrylates; Deoxycytidine; Drug Carriers; Gemcitabine; Hydrogen-Ion Concentration; Injections, Intravenous; Leukemia L1210; Mice; Mice, Inbred DBA; Nanoparticles; Polymers

2009
Characterization of a gemcitabine-resistant murine leukemic cell line: reversion of in vitro resistance by a mononucleotide prodrug.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2004, Aug-15, Volume: 10, Issue:16

    Topics: Animals; Antimetabolites, Antineoplastic; Base Sequence; Cell Survival; Deoxycytidine; Disease Models, Animal; DNA Primers; Drug Resistance, Neoplasm; Gemcitabine; Gene Expression Regulation, Neoplastic; Kinetics; Leukemia L1210; Mice; Polymerase Chain Reaction; Time Factors

2004
Gemcitabine-induced apoptosis in a drug-resistant mouse leukemia L1210 cell line that does not express p53.
    Advances in enzyme regulation, 2004, Volume: 44

    Topics: Animals; Antimetabolites, Antineoplastic; Apoptosis; Cell Cycle; Cell Division; Cell Line, Tumor; Deoxyadenosines; Deoxycytidine; Drug Resistance, Neoplasm; Flavonoids; Gemcitabine; Leukemia L1210; Methotrexate; Mice; Piperidines; Tumor Suppressor Protein p53

2004
Effects of 2',2'-difluorodeoxycytidine (Gemcitabine) on wild type and variant mouse leukemia L1210 cells.
    Oncology research, 1993, Volume: 5, Issue:2

    Topics: Animals; Antimetabolites, Antineoplastic; Carbon Radioisotopes; Cytidine; Deoxycytidine; Gemcitabine; Leukemia L1210; Mice; Ribonucleotide Reductases; Tumor Cells, Cultured

1993
Interactions of 2',2'-diflurodeoxycytidine (gemcitabine) with tumor necrosis factor alpha or its mutein VI in murine leukemias L1210 and P388.
    Archivum immunologiae et therapiae experimentalis, 1998, Volume: 46, Issue:2

    Topics: Animals; Antimetabolites, Antineoplastic; Deoxycytidine; Drug Interactions; Gemcitabine; Leukemia L1210; Leukemia P388; Male; Mice; Tumor Necrosis Factor-alpha

1998
Decreased resistance to gemcitabine (2',2'-difluorodeoxycitidine) of cytosine arabinoside-resistant myeloblastic murine and rat leukemia cell lines: role of altered activity and substrate specificity of deoxycytidine kinase.
    Biochemical pharmacology, 1999, Feb-15, Volume: 57, Issue:4

    Topics: Animals; Antimetabolites, Antineoplastic; Cell Division; Cytarabine; Cytidine Deaminase; Deoxycytidine; Deoxycytidine Kinase; DNA; Drug Resistance; Gemcitabine; Leukemia L1210; Mice; Nucleoside Deaminases; Polyphosphates; Rats; Rats, Inbred BN; Substrate Specificity; Thymidine Kinase; Tumor Cells, Cultured

1999
Additive action of gemcitabine (2',2'-difluorodeoxycytidine) and 2-chlorodeoxyadenosine on murine leukemias L1210 and P388.
    Cancer investigation, 1999, Volume: 17, Issue:2

    Topics: Animals; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cladribine; Deoxycytidine; Drug Administration Schedule; Drug Screening Assays, Antitumor; Drug Synergism; Gemcitabine; Leukemia L1210; Leukemia P388; Male; Mice

1999
Evaluation of the antitumor activity of gemcitabine (2',2'-difluoro-2'-deoxycytidine).
    Cancer research, 1990, Jul-15, Volume: 50, Issue:14

    Topics: Animals; Antimetabolites, Antineoplastic; Cell Line; Cell Survival; Deoxycytidine; Drug Evaluation, Preclinical; Drug Screening Assays, Antitumor; Female; Flow Cytometry; Gemcitabine; Humans; Leukemia L1210; Leukemia P388; Leukemia, Experimental; Male; Mice; Mice, Inbred ICR; Mice, Inbred Strains; Neoplasms, Experimental; Tumor Cells, Cultured

1990